Horizon Therapeutics Public Ltd Co

Woodline Partners LP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

170,848

Value ($000)

19,765

Weight

0.2%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	19,765	0.2%	170,848	9/30/2023
2023 Q2	8/14/2023	40,396	0.5%	392,763	6/30/2023
2023 Q1	5/15/2023	39,807	0.6%	364,734	3/31/2023
2022 Q4	2/14/2023	33,884	0.5%	297,749	12/31/2022
2022 Q3	11/14/2022	143,997	2.1%	2,326,663	9/30/2022
2022 Q2	8/15/2022	18,985	0.3%	238,028	6/30/2022
2022 Q1	5/16/2022	40,326	0.7%	383,288	3/31/2022
2021 Q4	2/14/2022	95,163	1.4%	883,103	12/31/2021
2021 Q3	11/15/2021	118,765	2.0%	1,084,213	9/30/2021
2021 Q2	8/16/2021	101,525	1.9%	1,084,209	6/30/2021
2021 Q1	5/17/2021	42,050	0.9%	456,871	3/31/2021
2020 Q4	2/16/2021	10,582	0.3%	144,661	12/31/2020
2020 Q3	11/16/2020	72,678	2.4%	935,603	9/30/2020
2020 Q2	8/14/2020	79,033	3.1%	1,421,974	6/30/2020
2020 Q1	5/15/2020	37,721	2.7%	1,273,494	3/31/2020
2019 Q4	2/14/2020	76,750	3.1%	2,120,156	12/31/2019